Pasaoglu Isil, Cakir Mehmet
University of Health Sciences, Beyoglu Eye Training and Research Hospital, Istanbul, Turkey.
Turkiye Hospital, Istanbul, Turkey.
Beyoglu Eye J. 2021 Sep 27;6(3):243-248. doi: 10.14744/bej.2021.38278. eCollection 2021.
This study evaluated the anatomical and functional results of 23-G transconjunctival sutureless vitrectomy (TSV) in diabetic retinopathy (DR) patients with a variety of vitreoretinal diseases.
Consecutive patients who underwent 23-G TSV for complications of DR were evaluated retrospectively. The primary outcome measures were best-corrected visual acuity (BCVA), intraocular pressure (IOP), and intraoperative and postoperative complications.
A total of 42 eyes of 41 patients were included and followed up for a mean of 15.64±10.0 months. The mean patient age was 59.33±7.4 years. Indications for surgery were nonclearing vitreous hemorrhage (VH) (n=10), tractional retinal detachment (TRD) (n=8), TRD+VH (n=12), epiretinal membrane (n=5), diabetic macular edema (n=3), submacular hemorrhage (n=2), macular hole (n=1), or vitreomacular traction (n=1). There was a significant improvement in the BCVA at the postoperative first and third months, and at the last visit compared with the preoperative value (p<0.001). There was no significant change in the mean IOP measured on the postoperative first day, first week, first month, third month, or the last visit (p>0.05). In the postoperative period, the VH resolved spontaneously in 9 eyes. Repeat 23-G vitrectomy was performed in 6 eyes: 4 with recurrent retinal detachment and 2 with VH.
The results indicate that 23-G TSV is an effective technique for vitreoretinal disease in patients with DR.
本研究评估了23G经结膜无缝合玻璃体切除术（TSV）在患有各种玻璃体视网膜疾病的糖尿病视网膜病变（DR）患者中的解剖和功能结果。
对因DR并发症接受23G TSV的连续患者进行回顾性评估。主要观察指标为最佳矫正视力（BCVA）、眼压（IOP）以及术中及术后并发症。
共纳入41例患者的42只眼，平均随访15.64±10.0个月。患者平均年龄为59.33±7.4岁。手术指征包括不吸收的玻璃体出血（VH）（n=10）、牵拉性视网膜脱离（TRD）（n=8）、TRD+VH（n=12）、视网膜前膜（n=5）、糖尿病性黄斑水肿（n=3）、黄斑下出血（n=2）、黄斑裂孔（n=1）或玻璃体黄斑牵拉（n=1）。术后第1个月、第3个月及末次随访时的BCVA与术前值相比有显著改善（p<0.001）。术后第1天、第1周、第1个月、第3个月或末次随访时测量的平均IOP无显著变化（p>0.05）。术后，9只眼的VH自发消退。6只眼进行了再次23G玻璃体切除术：4只眼因复发性视网膜脱离，2只眼因VH。
结果表明，23G TSV是治疗DR患者玻璃体视网膜疾病的有效技术。
